Page last updated: 2024-12-07

phosphoramide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

phosphoramide: RN given refers to triamide [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

phosphoramide : A compound in which one or more of the OH groups of phosphoric acid have been replaced with an amino or substituted amino group. The term is commonly confined to the phosphoric triamides, P(=O)(NR2)3, since replacement of one or two OH groups produces phosphoramidic acids: P(=O)(OH)(NR2)2 , P(=O)(OH)2(NR2). [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID123317
MeSH IDM0046987

Synonyms (31)

Synonym
hg 010 (phosphate)
triamidophosphate
phosphoryl triamide (po(nh2)3)
if 2303
phosphorus oxide triamide
ai3-51162
ii 17t4
ii 17t1
phosphorus oxytriamide
tris-aminophosphine oxide
phosphorooxytriamide
phosphoryl amide
sumitard xl
phosphoroxytriamide
hg 010
triaminophosphine oxide
phosphoric acid triamide
phosphotriamide
phosphoric triamide
phosphoramide
13597-72-3
phosphoric triamide(6ci,7ci,8ci,9ci)
m27wlz6cwp ,
unii-m27wlz6cwp
phosphoryl triamide
phosphine oxide, triamino-
triamidophosphat
DMSZORWOGDLWGN-UHFFFAOYSA-N
DTXSID40159607
Q22693530
p o (n h2)3

Research Excerpts

Actions

ExcerptReferenceRelevance
"The phosphoramide moiety of plays an indispensable role in this reaction."( Highly enantioselective Michael addition of 3-arylthio- and 3-alkylthiooxindoles to nitroolefins catalyzed by a simple cinchona alkaloid derived phosphoramide.
Gao, WM; Liu, YL; Wu, HH; Yu, JS; Zhao, YL; Zhou, F; Zhou, J, 2014
)
1.08

Toxicity

ExcerptReferenceRelevance
"The safe and efficient delivery of nucleic acids into haematopoietic stem cells (HSCs) has a wide range of therapeutic applications."( KLN-5: a safe monocationic lipophosphoramide to transfect efficiently haematopoietic cell lines and human CD34+ cells.
Clément, JC; Delépine, P; Férec, C; Fichou, Y; Hardy, E; Le Bris, M; Le Ny, K; Montier, T; Picquet, E; Yaouanc, JJ, 2004
)
0.61

Pharmacokinetics

ExcerptReferenceRelevance
" Then in vivo pharmacokinetic evaluations of six of the compounds were conducted."( Pharmacokinetics of amino acid phosphoramidate monoesters of zidovudine in rats.
Griesgraber, GW; Song, H; Wagner, CR; Zimmerman, CL, 2002
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (71)

TimeframeStudies, This Drug (%)All Drugs %
pre-199027 (38.03)18.7374
1990's3 (4.23)18.2507
2000's20 (28.17)29.6817
2010's19 (26.76)24.3611
2020's2 (2.82)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.79

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.79 (24.57)
Research Supply Index4.36 (2.92)
Research Growth Index4.93 (4.65)
Search Engine Demand Index82.50 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.79)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other77 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]